Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Cached at server time: 09:24:13
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Enzalutamide 40mg Tablet
Dosage Form : Tablet
Packaging Type : Blister
Packaging : 10*10
Price : ₹0/-
Enzasil Tablet is a critical and advanced pharmaceutical solution in the fight against advanced prostate cancer. Each tablet contains Enzalutamide 40mg, a powerful second-generation androgen receptor inhibitor. This targeted therapy works by blocking the effect of male hormones (androgens) on cancer cells, preventing their growth and spread. It is a cornerstone of treatment for patients with metastatic castration-resistant prostate cancer (mCRPC), both before and after chemotherapy. By effectively disrupting the hormonal signaling that fuels cancer progression, Enzasil plays a vital role in disease control and extending the lives of patients.
The oncology market, and specifically the segment for prostate cancer hormonal therapies, is a high-growth, high-value area within the Indian pharmaceutical industry. With the rising incidence of prostate cancer and a greater emphasis on targeted hormonal therapies, the demand for essential drugs like Enzalutamide is both robust and consistent. As a vital component of long-term cancer care regimens, this product ensures high turnover and a stable, recurring revenue stream. This makes the Enzasil franchise a strategic and highly profitable opportunity, allowing you to establish a strong presence in the super-specialty oncology market.
We are dedicated to empowering our franchise partners with all the tools necessary for success in this professional market. Our product is manufactured in a WHO-GMP certified facility, ensuring impeccable quality, efficacy, and safety, which is paramount for a life-saving oncology drug. We provide a complete promotional and marketing kit, including detailed product literature and clinical data, to support your engagement with specialized healthcare professionals. Our robust supply chain guarantees timely delivery and continuous stock availability, preventing any business interruptions. Partner with us to enter this lucrative market and establish a reputable and successful business as a key supplier of this critical and top-quality medicine.
Common side effects may include low blood counts, hair loss, nausea, vomiting, diarrhea, fatigue, neuropathy, and fluid retention. Serious side effects can include allergic reactions, severe neutropenia, liver toxicity, cardiac issues, and pulmonary complications.
Metastatic or locally advanced breast cancer Non-small cell lung cancer (NSCLC) Hormone-refractory prostate cancer Advanced gastric cancer Head and neck cancers To be used strictly under oncologist supervision.
Administer only in a hospital or clinical setting with trained personnel. Premedication with corticosteroids is often recommended to reduce hypersensitivity reactions. Regular monitoring of blood counts, liver and kidney function is essential. Report any infection, bleeding, or unusual symptoms promptly. Avoid direct contact with skin or eyes during preparation and administration.
Store below 25°C in a cool, dry, and dark place. Do not freeze. Keep out of reach of children and follow oncology guidelines for use and disposal.
Composition : Letrozole (2.5mg) Tablet
Composition : Danazol (100mg)
Composition : Danazol 200mg Capsule
Composition : Levofloxacin (250mg) + Ornidazole (500mg)
Composition : Ofloxacin (200mg) + Ornidazole (500mg)
Composition : Norfloxacin (400mg) + Tinidazole (600mg)
Composition : Faropenem (200mg)
Composition : Faropenem (200mg) + Clavulanic Acid (125mg)
Composition : Faropenem (300mg)